Pages that link to "Q74552281"

The following pages link to Differential expression of epidermal growth factor receptor in human head and neck cancers (Q74552281):

Displaying 29 items.

• Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions (Q27692631) (← links)
• Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck (Q28346765) (← links)
• RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology (Q33723572) (← links)
• The unexplained survival of cells in oral cancer: what is the role of p53? (Q34570837) (← links)
• The role of epidermal growth factor receptor in head and neck squamous cell carcinoma (Q35065193) (← links)
• mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer (Q35139024) (← links)
• Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family (Q35173073) (← links)
• Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies (Q35991729) (← links)
• The evolution of predictive oncology and molecular-based therapy for oral cancer prevention (Q36028406) (← links)
• Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. (Q37178534) (← links)
• Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck (Q37282274) (← links)
• Targeted therapies in squamous cell carcinoma of the head and neck (Q37373573) (← links)
• Molecular therapy in head and neck oncology (Q37458175) (← links)
• Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case-control study (Q37605840) (← links)
• Current chemotherapies for recurrent/metastatic head and neck cancer (Q37816174) (← links)
• Expression of protease-activated receptor 1 in oral squamous cell carcinoma (Q40795801) (← links)
• Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo (Q42142824) (← links)
• Strategies for non-resectable head and neck cancer (Q43978706) (← links)
• Gefitinib (ZD1839) in Previously Treated Advanced Non-Small-Cell Lung Cancer: Experience from a Single Institution (Q44634369) (← links)
• Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas. (Q53404030) (← links)
• Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity. (Q53501921) (← links)
• Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines (Q73380372) (← links)
• Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck (Q73917024) (← links)
• Tumor differentiation-dependent local immunity in human head and neck cancers (Q74266137) (← links)
• Editorial comment on 'Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma' by Hogg and colleagues (Q74523057) (← links)
• Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy (Q77839075) (← links)
• Zinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumors (Q77905354) (← links)
• [Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach] (Q84582074) (← links)
• Oral cancer research in the new millennium (Q95810910) (← links)